According to the TechSci Research report titled “Exosome Research Market – Global Industry Size, Share, Trends, Opportunities, and Forecast, 2018-2028,” the worldwide exosome research market is expected to experience impressive growth during the forecast period. This growth can be attributed to several factors, including advancements in exosome isolation and analytical procedures, increasing government and non-government initiatives for exosome research, and the rising prevalence of cancer worldwide.
Moreover, the market’s growth is driven by the increasing need to identify cancer biomarkers, detect infectious agents, and discover treatment options for neurodegenerative and cardiovascular diseases (CVDs). The demand for fast, accurate, and minimally invasive diagnostic procedures presents a promising opportunity for the growth of exosome applications, further boosting the global exosome research market.
Additionally, the exosome research market is benefiting from heightened research programs focusing on understanding the significance of exosomes in hepatocellular carcinoma (HCC) during the forecast period. However, a lack of standardized protocols for exosome isolation, analysis, and characterization currently poses challenges for researchers to compare and replicate findings across studies, potentially slowing down market growth. The complex and evolving regulatory environment for exosome-based products and services may also limit the expansion of the global exosome research market. Furthermore, the current methods for exosome isolation and analysis can be time-consuming and costly, potentially hampering market growth.
The exosome research market can be segmented by product, indication, application, and region. In terms of product, the global market includes kits and reagents, instruments, and other products. The kits and reagents segment dominated the market in 2022 and is expected to maintain its dominance throughout the forecast period. This is attributed to the increased need for molecular diagnosis and the surge in research and development (R&D) activities for diagnosis, driven by advancements in the healthcare sector and an increase in the number of key manufacturers.
Regarding applications, the market can be categorized into biomarkers, vaccine development, tissue regeneration, and other applications. The biomarkers segment is projected to dominate during the forecast period due to the growing demand for treating different cancers, such as melanoma patients, and the increasing incidence of neurodegenerative diseases. Additionally, the pursuit of research and development activities for novel drugs to treat chronic diseases is expected to create lucrative growth opportunities during the forecast period.
Browse over XX market data figures spread through xx pages and an in-depth TOC on the “Global Exosome Research Market.” – https://www.techsciresearch.com/report/exosome-research-market/15566.html
Major companies operating in the global exosome research market are:
- Thermo Fisher Scientific
- System Biosciences
- Bio-Techne
- Lonza
- QIAGEN
- ExoDx
- Hitachi Chemical
- Aethlon Medical
- NanoSomiX
- Malvern Panalytical
- Sistemic Scotland Limited
- NX PharmaGen
July 2022: Cells for Cells, a clinical-stage biotech pioneering allogeneic stem cell and stem-cell-derived therapeutics for high-impact chronic diseases, announced a 6-month follow-up of the groundbreaking clinical data from the first-ever patient dosed with an exosome-produced therapy for osteoarthritis.
April 2022: Global Stem Cells Group (GSCG) announced the launch of its new product with new lyophilized exosome technology. Global Stem Cells Group’s new product line includes innovative anti-aging products that can regenerate cells and tissues in the body.
November 2021: Lonza, a global manufacturing partner to the pharma, biotech, and nutrition industries, announced the acquisition of an exosome manufacturing facility in Lexington, Massachusetts (US) from Codiak BioSciences, a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics.
“North America is expected to dominate the global exosome research market during the forecast period on account of the improved healthcare facilities, efficacious government initiatives, a large foundation of multi-national corporations, and increased public consciousness concerning diagnostics and medicare. Similarly, A huge proportion of government-funded scientific analyses have been performed on the vocation of drugs containing exosomes in various types of cancers, including melanoma, breast cancer, lung cancer, and pancreatic cancer, among many that are expected to create lucrative growth in the market during the forecast period. Also, the increasing wide uptake of emerging micro-nanotechnologies for extracellular vesicles in immuno-oncology ranging from target-specific isolations to immunomodulation is expected to drive the growth of the market during the forecast period.
Furthermore, a surge in government-funded research studies, conducted regarding the role of drugs using exosomes in several types of cancer, such as melanoma, breast cancer, lung cancer, and pancreatic cancer, will further be expected to create lucrative opportunities for market growth,” said Mr. Karan Chechi, Research Director at TechSci Research, a research-based global management consulting firm.
Exosome Research Market – Global Industry Size, Share, Trends, Opportunities, and Forecast, 2018-2028, Segmented by Product (Kits and Reagents, Instruments, and Other Products), By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, and Others), By Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), By Region and Competition has evaluated the future growth potential of global exosome research market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global exosome research market.
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com
